Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells.
Morcos M, Schlotterer A, Sayed AA, Kukudov G, Oikomonou D, Ibrahim Y, Pfisterer F, Schneider J, Bozorgmehr F, Rudofsky G Jr, Schwenger V, Kientsch-Engels R, Hamann A, Zeier M, Dugi K, Yard B, Humpert PM, van der Woude F, Nawroth PP, Bierhaus A.
Morcos M, et al. Among authors: rudofsky g jr.
Horm Metab Res. 2008 Nov;40(11):752-9. doi: 10.1055/s-0028-1082039. Epub 2008 Aug 18.
Horm Metab Res. 2008.
PMID: 18711692